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AKT1 Gene Polymorphisms and Obstetric Complications 




ObjectiveaaWe performed a genetic association study with schizophrenic patients to inves-
tigate whether the V-akt murine thymoma viral oncogene homolog 1 (AKT1) gene plays a 
role in obstetric complications. 
MethodsaaOne-hundred-eighty patients with schizophrenia (male, 113; female, 67) were 
included. All patients fulfilled DSM-IV criteria for schizophrenia. Obstetric complications 
were measured by the Lewis scale. Prenatal and perinatal information was retrospectively 
collected from the patients’ mothers. We selected six single nucleotide polymorphisms (SNPs) 
for the AKT1 gene: SNP1 (rs3803300), SNP2 (rs1130214), SNP3 (rs3730358), SNP4 (rs 
1130233), SNP5 (rs2494732), and SNPA (rs2498804). The genotype data were analyzed 
for an association with the Lewis total score in terms of allele, genotype, and haplotype 
distribution. 
ResultsaaThe mean total Lewis scores were 1.30±1.61 for males and 1.54±1.87 for fe-
males. Higher total score tended to be correlated with an earlier age of onset of schizoph-
renia in females. In the total sample, no SNP was associated with obstetric complications. 
However, the additional analyses for male and female subgroups found a significant asso-
ciation between SNPA and SNP4 and Lewis score in females (p=0.02 for SNPA, p=0.04 for 
SNP4). The SNP5-SNPA haplotype showed a positive association with obstetric complic-
ations (p=0.03) in the female patient group. 
ConclusionaaWe found an association between SNPs in the AKT1 gene and total Lewis 
score measuring obstetric complications in female patients with schizophrenia. Because these 
findings did not survive a correction for multiple testing, the significance should be interpreted 
carefully and replication studies are required. 
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The prevalence of obstetric complications is higher in patients with schizophrenia
than in the general population.
1,2 A nongenetic developmental understanding of schi-
zophrenia has usually considered prenatal, perinatal, and postnatal obstetric compli-
cations,
3 but serious obstetric complications interact with genetic factors to increase
the risk for schizophrenia.
1,4 Various kinds of obstetric complications occur, but most 
cause hypoxia to the subject, and hypoxia is an important external factor influencing
schizophrenia susceptibility.
5 Molecular systems regulating hypoxia are especially 
crucial for development of the brain during the intrauterine period; therefore, dys-
function of this system could be one of the causes of schizophrenia.
6 About 50% of 
candidate genes for schizophrenia also appear to be associated with ischemia-hypo-
xia regulation and vascular expression.
5 
The development of schizophrenia involves an interaction of genetic and environ-
mental factors, and obstetric complications may interact as an environmental factor
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a phenotypic result of genes related to intrauterine fetal 
development and perinatal events. A recent study by Ni-
codmus et al.
7 found an interaction between hypoxia-
regulated vascular-expression genes and serious obstetric 
complications in schizophrenia risk. They found signifi-
cant evidence for a gene x environment interaction in V-
akt murine thymoma viral oncogene homolog 1 (AKT1), 
brain-derived neurotrophic factor (BDNF), dystrobrevin 
binding protein 1 (DTNBP1), and glutamate receptor me-
tabotrophic (GRM) genes in developing schizophrenia. 
The AKT1 gene is located on chromosome 14q32.32 
and is known to mediate growth factor-induced neuronal 
survival in the developing nervous system. The activat-
ion of AKT1 occurs through phosphatidylinositol 3-ki-
nase  (PI3K). The PI3K/AKT pathway plays a crucial 
role in signal transduction of cell growth, survival, and 
metabolism.
8 The functional role of the PI3K/AKT path-
way in ischemia-hypoxia regulation and neuroprotection 
has been studied.
9-13 AKT blocks apoptotic stimuli by 
inactivating pro-apoptotic proteins. AKT also exerts an-
tiapoptotic effects by activating endothelial nitric oxide 
synthase (eNOS).
14 
Previous studies suggested that AKT1 plays an im-
portant role in the pathophysiology of schizophrenia, and 
AKT phosphorylation in the rat frontal cortex after acute 
and chronic treatment with MK-801 are well known ani-
mal models of schizophrenia.
15 Reduced AKT protein and 
RNA levels have been reported in studies of postmortem 
brains of patients with schizophrenia.
16,17 Kalkman sug-
gested that reduced activity of the PI3K/AKT pathway 
makes the brain more susceptible to viral infections, an-
oxia, and obstetric complications.
18 The AKT1 gene has 
also been reported as a susceptibility gene for schizoph-
renia in genetic association studies.
19-21  
We previously collected Lewis scale data for patients 
with schizophrenia. These patients have been genotyped 
for six SNPs of AKT1 to identify a possible association 
with a schizophrenia diagnosis. In this paper, we analyz-
ed these data to identify the association between AKT1 





The patients with schizophrenia were collected from 
three large psychiatric clinics in Korea. The same rese-
arch nurse collected clinical information including me-
dical records and additional information from the psy-
chiatrist in charge of treatment of the patient. This infor-
mation was reviewed in order to get consensus diagnoses 
by two psychiatrists. Not all but most subjects were ac-
tually interviewed using DIGS-K (Diagnostic Interview 
for Genetic Studies-Korean version).
22 This information 
also was used for consensus diagnosis. All patients fulfilled 
the DSM-IV diagnostic criteria for schizophrenia, and both 
the diagnosis of schizophrenia and age at onset were ev-
aluated. Detailed information about the genetic study was 
provided to all participants, who signed written consent 
forms. This study was approved by the Ethics Committee 
of Seoul National University Hospital. Subjects with a 
history of any kind of organic abnormality of the brain, 
alcohol-related mental problems, drug abuse, or other phy-
sical illnesses possibly manifesting with psychiatric symp-
toms were not included in this study. Finally, 180 pa-
tients with schizophrenia (113 males, 67 females) were in-
cluded. The mean age of the male patients was 33.50± 
7.06 years and that of females was 35.55±7.88 years (p= 
0.07). The mean age at onset of schizophrenia was 21.88± 
4.97 years for males and 24.22±6.18 years for females. 
A significant difference in age at onset was found between 
male and female patients (p=0.02).  
 
Obstetric complications 
The information on obstetric complications associated 
with each patient’s birth was collected from the mother 
through direct or phone interviews. We used the Lewis 
scale
23 to collect prenatal, perinatal, and postnatal infor-
mation on the patients. The Lewis scale consists of 16 in-
dividual items including information about rubella, syphilis, 
Rh incompatibility, pregnancy-induced hypertension, ob-
stetric bleeding, premature membrane rupture, labor dur-
ation, twin birth, cord prolapse, gestational age, Cesarean 
section, breech or abnormal presentation, instrumental deli-
very, birth weight, fetal distress, and gross physical anoma-
ly. Each item was evaluated as definite (score 2), equivocal 
(score 1), or absent (score 0). The total Lewis score was 
obtained by summing scores on the individual items.   
 
Genotyping 
DNA was extracted from blood samples using a DNA 
isolation kit (Roche, Mannheim, Germany). We selected 
six SNPs for the AKT1 gene: SNP1 (rs3803300), SNP2 
(rs1130214), SNP3 (rs3730358), SNP4 (rs1130233), SNP5 
(rs2494732), and SNPA (rs2498804). We selected those 
SNPs because SNP 1-5 have been studied in most of the 
papers on AKT and schizophrenia. The SNP A is included 
because it was studied in a Japanese association study of 
schizophrenia.
19 SNP1 and SNP4 were the SNPs found 
to be associated with serious obstetric complications in 
Nicodemus’ paper.
7 They are located in the 5’-UTR, in-
tron 1, intron 3, exon 9, intron 11, and 3’-UTR, respecti-
vely. TaqMan SNP genotyping assays were performed 
according to the protocol of Applied Biosystems (Foster 
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of the six SNPs selected for this study. 
 
Statistical analysis 
The Hardy-Weinberg equilibrium was tested to detect 
any possible genetic deviation in the study sample. The 
comparison of allele and genotype frequencies between 
patients with a high Lewis score (≥3) and patients with a 
low Lewis score (0-2) was performed by the chi-square 
test. If the cell counts less than 5, the significance from 
Fisher’s exact test was adopted. In this study, patients 
with a high Lewis score were those with obstetric com-
plications. The association between genotype and Lewis 
score was also analyzed by an analysis of variance (AN-
OVA). In this case, the obstetric complication (Lewis 
score) was treated as a continuous variable. Because a 
positive association was found only for the female pa-
tients, the linkage disequilibrium (LD) calculation between 
SNPs and the haplotype association test was done for 
female patients using UNPHASED 3.0.13 (http://www. 
mrc-bsu.cam.ac.uk/personal/frank/software/unphased/).
23 
The haplotype association was tested for two to six SNPs 
with sliding window methods. In this study the program 
calculated chi-square and p-value for a specific haplo-
type association with phenotype in the model of haplo-
type main effect. Usually LD was measured in both D’ 
and r
2. D’ means a measure of the proportion of the ma-
ximum possible LD given the allele frequencies
24 and r
2 
indicates a squared correlation coefficient between two 
loci. UNPHASED program analysed both D’ and r
2 be-




The total Lewis scores ranged from 0 to 8. No difference 
TABLE 1. Six single nucleotide polymorphisms (SNPs) of the
AKT1 gene 
Name dbSNP  Position  Location  Alleles 
SNP1 rs3803300  86270824  5'-UTR  A/G 
SNP2 rs1130214  86260779  Intron  1  G/T 
SNP3 rs3730358  86247452  Intron  3  C/T 
SNP4 rs1130233  86240939  Exon  9 G/A 
SNP5 rs2494732  86240237  Intron  11  A/G 
SNPA rs2498804 86234140 3'-UTR  G/T 
 
TABLE 2. Allele distribution of AKT1 gene single nucleotide polymorphisms (SNPs) with obstetric complications 
Total Male  Female 
SNPs 
Allele1 Allele2 Allele1 Allele2 Allele1 Allele2 
SNP1 (A/G) Low  195  119  120  078  075 41 
 High  031  015  020  008  011  07 
 Chi-square  0.48  1.22  0.09 
 p-value  0.49  0.27  0.77 
SNP2 (G/T) Low  266  048 171 027  095 21 
 High  040  006  027  001  013  05 
 Chi-square  0.16  2.29  0.93 
 p-value  0.69  0.22  0.33 
SNP3 (C/T) Low  290  024 181 017 109  07 
 High  041  005  024  004  017  01 
 Chi-square  0.56  0.95  0.01 
 p-value  0.45  0.31  1.00 
SNP4 (G/A) Low  144  168  091 107 053 61 
 High  027  019  014  014  013  05 
 Chi-square  2.53  0.16  4.12 
 p-value  0.11  0.69  0.04 
SNP5 (A/G) Low  095 219 063 135 032 84 
 High  011  035  006  022  005 13 
 Chi-square  0.78  1.25  0.00 
 p-value  0.38  0.26  0.99 
SNPA (G/T) Low  123  191  079 119 044 72 
 High  024  022  012  016  012  06 
 Chi-square  2.81  0.09  5.29 
 p-value  0.09  0.77  0.02 
SNP1: rs3803300, SNP2: rs1130214, SNP3: rs3730358, SNP4: rs1130233, SNP5: rs2494732, SNPA: rs2498804, Low:  group of schizophrenic 
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was found between the mean total Lewis scores for males 
(1.30±1.61) and females (1.54±1.87; p=0.37). About 
10% of patients showed relatively high Lewis scores 
(≥3; 12.39% in male; 13.43% in female). More than one-
third of patients had a total Lewis score of 0 (43.36% in 
male, 38.81% in female), indicating that their mother 
reported no obstetric complications.   
No correlation was found between total Lewis score 
and age at onset in male patients, whereas a higher total 
Lewis score tended to be correlated with earlier age at 
onset in females (Pearson correlation coefficient=-0.21, 
p=0.06). 
No deviations from the Hardy-Weinberg equilibrium 
were observed for the six SNPs of the AKT1 gene (data 
not shown). When the allelic distribution was compared 
between high and low total Lewis score in the total sam-
ple, no SNP was associated with obstetric complications. 
However, an additional analysis of the male and female 
subgroups found a significant association between SNPA 
and SNP4 and Lewis score in the female group only (p= 
0.02 for SNPA, p=0.04 for SNP4; Table 2). No signifi-
cant association by genotype distribution was observed 
for any of the SNPs (Table 3). However, an ANOVA be-
tween genotype and Lewis score found that SNPA was 
significantly associated with obstetric complications in 
the total sample (F=3.64, df=2, p=0.03), and a tendency 
was found for an association in the female patient group 
(F=2.73, df=2, p=0.07). This is consistent with the find-
ing of allelic association with SNPA. However, we found 
no genotypic association for SNP4 in any subgroup of the 
sample. Because more evidence supported a positive as-
sociation in females, the haplotype analysis was perform-
ed only for the female subgroup. SNP4 and SNP5 were 
closely adjacent to each other and the SNP5-SNPA haplo-
type showed a positive association with obstetric com-
plications (p=0.03). The SNP4-SNP5 and SNP4-SNP5-
SNPA haplotypes also showed positive associations (p= 




We found an association in female patients with sch-
TABLE 3. Genotype distribution of the AKT1 gene single nucleotide polymorphisms (SNPs) with obstetric complications 
Total Male  Female 
SNPs 
G11 G12 G22 G11 G12 G22 G11 G12 G22 
SNP1 (A/G) Low  061  73 23 36 48 15 25 25 08 
 High  012  07  04  08  04  02  04  03  02 
 Chi-square  2.14 2.42 0.55 
 p-value  0.34 0.30 0.76 
SNP2 (G/T) Low  113  40  04 74 23 02 39 17 02 
 High  018  04  01 13 01  00  05  03  01 
 Chi-square  0.88 2.30 1.23 
 p-value  0.64 0.32 0.54 
SNP3 (C/T) Low  133  24  00 82 17 00 51 07  00 
 High  018  05  00 10 04  00  08  01  00 
 Chi-square  0.62 1.05 0.01 
 p-value  0.54 0.29 1.00 
SNP4 (G/A) Low  034  76 46 21 49 29 13 27 17 
 High  009  09  05  04  06  04  05  03  01 
 Chi-square  3.32 0.41 4.39 
 p-value  0.19 0.81 0.11 
SNP5 (A/G) Low  013 69  75  09 45 45 04 24 30 
 High  002  07 14 01  04  09  01  03  05 
 Chi-square  1.57 1.77 0.33 
 p-value  0.46 0.41 0.85 
SNPA (G/T) Low  023  77 57 14 51 34 09 26 23 
 High  008  08  07  04  04  06  04  04  01 
 Chi-square  5.78 3.28 5.13 
 p-value  0.06 0.20 0.08 
SNP1: rs3803300, SNP2: rs1130214, SNP3: rs3730358, SNP4: rs1130233, SNP5: rs2494732, SNPA: rs2498804, Low: group of schizophrenic pa-
tients with Lewis score (0-2), High: group of schizophrenic patients with Lewis score (≥3), G11: genotype with homozygote of allele 1, G12:
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izophrenia between the SNPs in the AKT1 gene and to-
tal Lewis score measuring obstetric complications. Con-
sidering the allele, genotype, and haplotype association 
results, SNPA and SNP4 seem likely to be associated 
with obstetric complications. Although we could not in-
vestigate gene-environment interaction because of the 
lack of data, our finding indirectly implicates a possible 
role for the AKT1 gene in obstetric complications and 
schizophrenia. Because these findings did not survive a 
correction for multiple testing, their meaning should be 
interpreted carefully, and replication studies are required. 
Numerous endogenous stressors may occur during fe-
tal brain development, and dysregulation of neuropro-
tection could cause an abnormality in brain development 
that may result in schizophrenia. There is significant sup-
porting evidence, such as ventricular enlargement and 
decreased hippocampal volume,
26-28 that schizophrenia 
is caused by hypoxia-ischemia during neural development; 
hence, it would be reasonable to speculate that neuro-
vascular units would be important to normal brain deve-
lopment. Interestingly many genes play roles in both ne-
urons and in vascular endothelial cells, and neuronal and 
vascular development have been discovered to be pa-
rallel.
29 AKT1 is one of many candidate genes in schizo-
phrenia that are likely regulated by hypoxia and ex-
pressed in vascular systems.
5  
Our study suggested a possible role for the AKT1 gene 
in obstetric complications; the association was more no-
table in female patients with schizophrenia. Gender dif-
ferences in hypoxia-related brain insult have been sug-
gested by previous studies. After neonatal hypoxic-is-
chemia, apoptotic mechanisms may be activated differ-
ently in male and female brains, but the mechanism is 
not clear.
30 Differences in genetic association for hypo-
xic obstetric complications would be a possible cause 
for this kind of gender difference.   
There are several limitations to this study. First, no 
Lewis scale data were available for the control sample, 
and we could not include genotype data from control 
subjects for our analysis. Therefore, an analysis of the 
gene-environment interaction, i.e. AKT1 SNPs geno-
type-Lewis score for obstetric complications, could not 
be performed. Second, the Lewis scale was only avail-
able for 180 patients with schizophrenia. This sample size 
is not large to draw statistically valid conclusions, espe-
cially with rare alleles or haplotype effects on obstetric 
complications. Third, the information on obstetric com-
plications was collected retrospectively from patients’ 
mothers. Even though some studies have found that mo-
thers were able to recall obstetric complications decades 
after birth,
31,32 these retrospective data would have some 
bias.  
Fetal hypoxia has been considered an important envi-
ronmental risk factor for schizophrenia. Now it should 
be considered as an intermediate result of specific gene 
mutations. The genes involved are likely to be genes with 
dual neural and vascular-cell function. A dysregulation 
in AKT1 function, possibly due to genetic mutation, could 
cause schizophrenia developmentally through a hypoxic 
insult to the fetal brain or through other genetic effects 
on the brain function of schizophrenic patients. Many 
candidate genes may need to be tested to examine this 
hypothesis. Genetic factors play a role in environmental 
exposure of the subject has been hypothesized and is 
fairly widely accepted.
33 From this perspective, more 
studies on genes and various environmental stressors are 
warranted to understand the multiple-layered and com-
plex nature of the gene-environment interaction. 
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